Wave expects to initiate a Phase 2a multidose portion of WVE-007 INLIGHT clinical trial in individuals living with obesity with higher BMI and ...

SKYWAY (NCT07148414) is a Phase 2 basket trial of SPY072 (anti-TL1A) in patients with moderate to severely active RA, PsA, or axSpA. Enrollment is on track, and all indications are expected to readout ...

As it turns out, not everyone has a loan on their house. In fact, 40 percent of U.S. homes don’t have a mortgage, per the ...

GC Therapeutics, Inc. (GCTx), a biotechnology company created to scale and unlock the next generation of cell therapy-based medicines through its TFome™ cellular programming platform, today announced ...

From artificial intelligence to marketing, our alumni are shaping the future of business. Here's a glimpse of where they – ...

Good Friday morning. A new poll shows U.S. Rep. Byron Donalds leading the Republican field for Governor, ahead of declared ...

"6 in '26" expected proof-of-concept (POC) readouts across SKYLINE and SKYWAY trials SKYLINE platform trial in ulcerative colitis (UC) recruiting faster than expected with SPY001 enrollment complete ...

Stability studies measure how medical devices respond to environmental stresses such as temperature, humidity, light, and ...

The Poets&Quants recognition builds on a series of recent national rankings for Lerner’s online MBA program. In January 2025, ...

CoStar Group, Inc. (NASDAQ: CSGP), a leading provider of online real estate marketplaces, information, analytics, and 3D ...

Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced positive efficacy and safety results from the Phase 3 HERIZON-GEA-01 trial evaluating Ziihera® (zanidatamab-hrii) in combination with ...